Viral Conjunctivitis
Conditions
Brief summary
The purpose of this study is to determine the outcomes of treating epidemic keratoconjunctivitis with 2% povidone-iodine.
Detailed description
The study design was a prospective interventional case series. Our institutional ethical committee approved the study protocol in April 2004. We performed this study between July 2004 and December 2009. During this period, there were 2 episodes of EKC epidemic. The first episode was in 2006 and the second in 2009.
Interventions
DRUG2% povidone-iodine
apply 4 times a day for one week
Sponsors
Mahidol University
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
7 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patients who were diagnosed with EKC at the outpatient ophthalmic unit
Exclusion criteria
* children younger than six years * women being pregnant or during lactation * history of allergy to povidone-iodine * prior ocular surgery * contact lens usage and chronic eye diseases with current eye medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the recovery rate within one week of treatment | 1 week |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| drug tolerability | 1 week | proportion of patient who can continue topical application of povidone-iodine for a week or until EKC subsides |
Countries
Thailand
Outcome results
None listed